A detailed history of Investors Asset Management Of Georgia Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 15,890 shares of AZN stock, worth $1.23 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
15,890
Previous 15,890 -0.0%
Holding current value
$1.23 Million
Previous $1.07 Million 0.56%
% of portfolio
0.52%
Previous 0.55%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

SELL
$63.15 - $71.6 $126,300 - $143,200
-2,000 Reduced 11.18%
15,890 $1.1 Million
Q3 2022

Oct 27, 2022

SELL
$53.02 - $135.75 $5,302 - $13,575
-100 Reduced 0.56%
17,890 $981,000
Q2 2022

Aug 01, 2022

SELL
$59.26 - $71.14 $17,778 - $21,342
-300 Reduced 1.64%
17,990 $1.19 Million
Q4 2021

Feb 03, 2022

SELL
$54.02 - $63.83 $5,402 - $6,383
-100 Reduced 0.54%
18,290 $1.07 Million
Q4 2020

Jan 28, 2021

SELL
$48.52 - $58.02 $8,491 - $10,153
-175 Reduced 0.94%
18,390 $919,000
Q1 2020

Apr 21, 2020

SELL
$37.79 - $51.33 $41,569 - $56,463
-1,100 Reduced 5.59%
18,565 $829,000
Q4 2019

Jan 15, 2020

SELL
$42.46 - $50.46 $16,984 - $20,184
-400 Reduced 1.99%
19,665 $980,000
Q3 2019

Oct 17, 2019

SELL
$40.12 - $45.47 $14,042 - $15,914
-350 Reduced 1.71%
20,065 $894,000
Q2 2019

Jul 10, 2019

BUY
$37.28 - $41.68 $3,728 - $4,168
100 Added 0.49%
20,415 $843,000
Q1 2019

Apr 17, 2019

BUY
$35.49 - $43.02 $10,647 - $12,906
300 Added 1.5%
20,315 $821,000
Q4 2018

Jan 22, 2019

BUY
$36.86 - $41.49 $3,686 - $4,149
100 Added 0.5%
20,015 $760,000
Q2 2018

Jul 27, 2018

SELL
$34.55 - $37.05 $3,454 - $3,704
-100 Reduced 0.5%
19,915 $699,000
Q4 2017

Jan 11, 2018

SELL
$32.09 - $34.78 $8,824 - $9,564
-275 Reduced 1.36%
20,015 $695,000
Q3 2017

Nov 02, 2017

BUY
$28.96 - $34.0 $587,598 - $689,860
20,290
20,290 $687,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $239B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Investors Asset Management Of Georgia Inc Portfolio

Follow Investors Asset Management Of Georgia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.